Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study
{{output}}
Coronavirus disease 2019 (COVID-19) is a new pandemic characterized by quick spreading and illness of the respiratory system. To date, there is no specific therapy for Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). Flavonoids, especially rutin, ... ...
